As an ectonucleotidase that hydrolyzes extracellular ATP and ADP into AMP, CD39 regulates purinergic signaling across tumor cells, endothelial cells, myeloid populations, and exhausted CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.